Clinical studies have shown that the CXCL12–CXCR4/CXCR7 axis plays a role in survival, tumor growth, angiogenesis, metastasis, the tumor microenvironment, and drug resistance, making it a promising target for cancer treatment. The gene discussed is ACKR3; the disease is neoplasm.